Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

Arnaud Del Bello; Florence Abravanel; Olivier Marion; Chloé Couat; Laure Esposito; Laurence Lavayssière; Jacques Izopet; Nassim Kamar

doi:10.1111/ajt.16775

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

Am J Transplant. 2022 Jan;22(1):322-323. doi: 10.1111/ajt.16775. Epub 2021 Aug 31.

Authors

Arnaud Del Bello^{1

2

3}, Florence Abravanel^{2

3

4}, Olivier Marion^{1

2

3}, Chloé Couat¹, Laure Esposito¹, Laurence Lavayssière¹, Jacques Izopet^{2

3

4}, Nassim Kamar^{1

2

3}

Affiliations

¹ Department of Nephrology and Organs Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
² Paul Sabatier University, Toulouse, France.
³ INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
⁴ Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France.

No abstract available

Keywords: clinical research/practice; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; vaccine.

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Organ Transplantation*
RNA, Messenger
SARS-CoV-2
Transplant Recipients

Substances

COVID-19 Vaccines
RNA, Messenger